Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES

v3.24.3
ACCRUED EXPENSES
 9 Months Ended
Sep. 30, 2024
Payables and Accruals [Abstract]  
ACCRUED EXPENSES

10. ACCRUED EXPENSES

 

Accrued expenses consisted of the following (in thousands):

 

 

 

September 30,
2024

 

 

December 31,
2023

 

 

 

 

 

 

 

 

Accrued pre-clinical and clinical costs

 

$

1,628

 

 

$

1,449

 

Accrued product development costs

 

 

1,671

 

 

 

745

 

Accrued license costs

 

 

1,625

 

 

 

4,825

 

Accrued compensation

 

 

1,823

 

 

 

2,326

 

Accrued administrative costs

 

 

429

 

 

 

343

 

Accrued interest

 

 

—

 

 

 

1,342

 

Total

 

$

7,176

 

 

$

11,030